impower133: atezolizumab, carboplatin plus etoposide for sclc
Published 5 years ago • 856 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
0:26
results of celebrate: carboplatin, etoposide, bevacizumab atezolizumab es-sclc
-
6:33
a win for small–cell lung cancer: impower 133
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
2:35
atezolizumab in combination with carboplatin etoposide for heavily treated small cell lung cancer
-
3:36
highlights from wclc 2018: nelson, alta, impower133 & pacific
-
8:11
first-line immunotherapy: impower133 regimen
-
0:58
combining immunotherapy and chemotherapy in patients with sclc
-
5:06
impower133 in sclc
-
2:53
the current treatment landscape for sclc
-
2:01
chemoimmunotherapy, the uk & extensive-stage sclc
-
1:50
small cell lung cancer: interpreting data from impower133
-
2:54
best results ever in the treatment of small cell lung cancer: immunotherapy in primary care
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
2:53
first-line atezolizumab plus chemotherapy improves survival in lung cancer patients
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
1:41
adjuvant atezolizumab in nsclc